References
- P. Rawla, T. Sunkara and V. Gaduputi, Epidemiology of pancreatic cancer: Global trends, etiology and risk factors, World J. Oncol. 10(1) (2019) 10–27; https://doi.org/10.14740/wjon1166
- G. Lippi and C. Mattiuzzi, The global burden of pancreatic cancer, Arch. Med. Sci. 16(4) (2020) 820–824; https://doi.org/10.5114/aoms.2020.94845
- A. McGuigan, P. Kelly, R. C. Turkington, C. Jones, H. G. Coleman and R. S. McCain, Pancreatic cancer: A review of clinical diagnosis, epidemiology, treatment and outcomes, World J. Gastroenterol. 24(43) (2018) 4846–4861; https://doi.org/10.3748/wjg.v24.i43.4846
- E. G. Chiorean and A. L. Coveler, Pancreatic cancer: Optimizing treatment options, new, and emerging targeted therapies, Drug Des. Devel. Ther. 9 (2015) 3529–3545; https://doi.org/10.2147/DDDT.S60328
- D. R. Principe, P. W. Underwood, M. Korc, J. G. Trevino, H. G. Munshi and A. Rana, The current treatment paradigm for pancreatic ductal adenocarcinoma and barriers to therapeutic efficacy, Front. Oncol. 11 (2021) Article ID 88377 (25 pages); https://doi.org/10.3389/fonc.2021.688377
- J. Hunia, K. Gawalski, A. Szredzka, M. J. Suskiewicz and D. Nowis, The potential of PARP inhibitors in targeted cancer therapy and immunotherapy, Front. Mol. Biosci. 9 (2022) Article ID 1073797 (24 pages); https://doi.org/10.3389/fmolb.2022.1073797
- Y. You, X. Lai, Y. Pan, H. Zheng, J. Vera, S. Liu, S. Deng and L. Zhang, Artificial intelligence in cancer target identification and drug discovery, Signal Transduct. Target Ther. 7(1) (2022) Article ID 156 (24 pages); https://doi.org/10.1038/s41392-022-00994-0
- S. Dimitrov-Markov, J. Perales-Paton, B. Bockorny, A. Dopazo, M. Munoz, N. Banos, V. Bonilla, C. Menendez, Y. Duran, L. Huang, S. Perea, S. K. Muthuswamy, F. Al-Shahrour, P. P. Lopez-Casas and M. Hidalgo, Discovery of new targets to control metastasis in pancreatic cancer by single-cell transcriptomics analysis of circulating tumor cells, Mol. Cancer Ther. 19(8) (2020) 1751–1760; https://doi.org/10.1158/1535-7163.MCT-19-1166
- J. Yi, S. Li, C. Wang, N. Cao, H. Qu, C. Cheng, Z. Wang, L. Wang and L. Zhou, Potential applications of polyphenols on main ncRNAs regulations as novel therapeutic strategy for cancer, Biomed. Pharmacother. 113 (2019) Article ID 108703 (8 pages); https://doi.org/10.1016/j.biopha.2019.108703
- A. Vafadar, Z. Shabaninejad, A. Movahedpour, S. Mohammadi, S. Fathullahzadeh, H. R. Mirzaei, A. Namdar, A. Savardashtaki and H. Mirzaei, Long non-coding RNAs as epigenetic regulators in cancer, Curr. Pharm. Des. 25(33) (2019) 3563–3577; https://doi.org/10.2174/1381612825666190830161528
- L. Statello, C. J. Guo, L. L. Chen and M. Huarte, Gene regulation by long non-coding RNAs and its biological functions, Nat. Rev. Mol. Cell Biol. 22(2) (2021) 96–118; https://doi.org/10.1038/s41580-020-00315-9
- H. Sun, Z. Huang, W. Sheng and M. D. Xu, Emerging roles of long non-coding RNAs in tumor metabolism, J. Hematol Oncol. 11 (2018) Article ID 106 (16 pages); https://doi.org/10.1186/s13045-018-0648-7
- J. C. de Oliveira, L. C. Oliveira, C. Mathias, G. A. Pedroso, D. S. Lemos, A. Salviano-Silva, T. S. Jucoski, S. C. Lobo-Alves, E. P. Zambalde, G. A. Cipolla and D. F. Gradia, Long non-coding RNAs in cancer: Another layer of complexity, J. Gene Med. 21(1) (2019) e3065; https://doi.org/10.1002/jgm.3065
- Y. H. Lin, M. H. Wu, C. T. Yeh and K. H. Lin, Long non-coding RNAs as mediators of tumor micro-environment and liver cancer cell communication, Int. J. Mol. Sci. 19(12) (2018) Article ID 3742 (21 pages); https://doi.org/10.3390/ijms19123742
- Z. Ma, Y. Y. Wang, H. W. Xin, L. Wang, F. Arfuso, A. Dharmarajan, A. P. Kumar, H. Wang, F. R. Tang, S. Warrier, V. Tergaonkar and G. Sethi, The expanding roles of long non-coding RNAs in the regulation of cancer stem cells, Int. J. Biochem. Cell Biol. 108 (2019) 17–20; https://doi.org/10.1016/j.biocel.2019.01.003
- U. Sharma, T. S. Barwal, A. Malhotra, N. Pant, Vivek, D. Dey, A. Gautam, H. S. Tuli, K. M. Vasquez and A. Jain, Long non-coding RNA TINCR as potential biomarker and therapeutic target for cancer, Life Sci. 257 (2020) Article ID 118035; https://doi.org/10.1016/j.lfs.2020.118035
- S. Li, J. Li, H. Li, M. Gao, N. Li, Y. Wang, L. Tong, M. Song and Z. Yin, Clinicopathological and prognostic significance of TINCR in caner: A meta-analysis, Pathol. Res. Practice 215(10) (2019) Article ID 152596; https://doi.org/10.1016/j.prp.2019.152596
- S. Ghafouri-Fard, S. Dashti, M. Taheri and M. D. Omrani, TINCR: An lncRNA with dual functions in the carcinogenesis process, Non-coding RNA Res. 5(3) (2020) 109–115; https://doi.org/10.1016/j.ncrna.2020.06.003
- K. J. Livak and T. D. Schmittgen, Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method, Methods 25(4) (2001) 402–408; https://doi.org/10.1006/meth.2001.1262
- E. Ji, C. Kim, W. Kim and E. K. Lee, Role of long non-coding RNAs in metabolic control, Biochim. Biophys. Acta Gene Regul. Mech. 1863(4) (2020) Article ID 194348; https://doi.org/10.1016/j.bbagrm.2018.12.006
- M. E. Forrest and A. M. Khalil, Review: Regulation of the cancer epigenome by long non-coding RNAs, Cancer Lett. 407 (2017) 106–112; https://doi.org/10.1016/j.canlet.2017.03.040
- Q. Huang, J. Yan and R. Agami, Long non-coding RNAs in metastasis, Cancer Metastasis Rev. 37(1) (2018) 75-81; https://doi.org/10.1007/s10555-017-9713-x
- X. Han, Y. Jia, X. Chen, C. Sun and J. Sun, lncRNA TINCR attenuates the proliferation and invasion, and enhances the apoptosis of cutaneous malignant melanoma cells by regulating the miR-424-5p/LATS1 axis, Oncol. Rep. 46(5) (2021) Article ID 238 (11 pages); https://doi.org/10.3892/or.2021.8189
- Y. Wang, L. Zhou, J. Lu, B. Jiang, C. Liu, J. Guo and G. G. Xiao, Research progress on long non-coding RNAs and their roles as potential biomarkers for diagnosis and prognosis in pancreatic cancer, Cancer Cell Int. 20 (2020) Article ID 457 (12 pages); https://doi.org/10.1186/s12935-020-01550-y
- D. Lu, S. Di, S. Zhuo, L. Zhou, R. Bai, T. Ma, Z. Zou, C. Chen, M. Sun, J. Tang and Z. Zhang, The long noncoding RNA TINCR promotes breast cancer cell proliferation and migration by regulating OAS1, Cell Death Discov. 7(1) (2021) Article ID 41 (16 pages); https://doi.org/10.1038/s41420-021-00419-x
- X. Liu, J. Ma, F. Xu and L. Li, TINCR suppresses proliferation and invasion through regulating miR-544a/FBXW7 axis in lung cancer, Biomed. Pharmacother. 99 (2018) 9–17; https://doi.org/10.1016/j.biopha.2018.01.049
- M. Esposito, S. Ganesan and Y. Kang, Emerging strategies for treating metastasis, Nat. Cancer 2(3) (2021) 258–270; https://doi.org/10.1038/s43018-021-00181-0
- N. M. Novikov, S. Y. Zolotaryova, A. M. Gautreau and E. V. Denisov, Mutational drivers of cancer cell migration and invasion, Br. J. Cancer 124(1) (2021) 102–114; https://doi.org/10.1038/s41416-020-01149-0
- J. Winkler, A. Abisoye-Ogunniyan, K. J. Metcalf and Z. Werb, Concepts of extracellular matrix remodelling in tumour progression and metastasis, Nat. Commun. 11 (2020) Article ID 5120 (19 pages); https://doi.org/10.1038/s41467-020-18794-x
- D. Lu, S. Di, S. Zhuo, L. Zhou, R. Bai, T. Ma, Z. Zou, C. Chen, M. Sun, J. Tang and Z. Zhang, The long noncoding RNA TINCR promotes breast cancer cell proliferation and migration by regulating OAS1, Cell Death Discov. 7(1) (2021) Article ID 41 (16 pages); https://doi.org/10.1038/s41420-021-00419-x
- Y. Zhang and X. Wang, Targeting the Wnt/beta-catenin signaling pathway in cancer, J. Hematol. Oncol. 13 (2020) Article ID 165 (16 pages); https://doi.org/10.1186/s13045-020-00990-3